We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.80 | 8.44% | 48.80 | 48.00 | 49.00 | 49.00 | 45.00 | 45.00 | 5,721,464 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.51 | 137.55M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/8/2017 21:03 | Interesting. But I still want to know,Why do you think bad news is coming? | lantanatony | |
02/8/2017 18:27 | E1nstein Do you be read RNS ? I count 5 or 6 so far this year | lentjes | |
02/8/2017 17:42 | What proof do you have that Alastair is "running around the country with the begging bowl"? | e1nstein | |
02/8/2017 17:15 | Why else would Alastair be running around the country with the begging bowl unless the cash from the last fund raise was running low and no sign of revenue. If cash was not a problem his time would be better spent increasing revenue with contracts and not chasing investors for more money. | lentjes | |
02/8/2017 16:27 | Why expecting bad news? Where do you get that from? | lantanatony | |
02/8/2017 14:27 | Looks like trading update due and expecting bad news although volume low. Maybe being dropped for a placing as Alastair has been doing the rounds lately with the collection tin | lentjes | |
19/7/2017 15:31 | There was a positive trading statement issued last year on 1st August. Since then: Positive results RNS 22nd September 16 First Affimer pre-clinical 1st November 16 CAR-T collaboration 2nd November 16 Affinity separation 23rd November 16 Immunogenicity Results 3rd April 17 Diagnostic firm deal 24th April 17 Two leading US Biotech's RNS 22nd May 17 Together with the ongoing collaborations (Moderna et al) the cash position will make for interesting reading, as will any deals that might be signed where we qualify for royalties.... our own cancer therapeutic remains the single-most transformational item in the pipeline, so let us all hope that one or more of these is coming close to fruition, and the market starts liking AVCT. For me, we are in the best position we ever have been as a business, but are unappreciated by the market based on past failings. Here's to a step change in appreciation soon. | the drewster | |
10/7/2017 12:54 | Avacta’s Chief Executive Alastair Smith presents at our Manchester seminar tomorrow located at Double Tree by Hilton Manchester Piccadilly. See for more details. | sharesoc | |
04/7/2017 18:30 | If you have not already booked a place for our Manchester seminar on the 11th July, it may be of interest and well worth attending: Avacta’s Chief Executive Alastair Smith, will be delivering the presentation and will be open to questions! | sharesoc | |
03/7/2017 13:22 | Anyone know what today's excitement is about? Price shot up almost like a news item. | mrangry2 | |
29/6/2017 09:27 | Cheers for that E..... | spekky | |
28/6/2017 08:58 | Interesting article just appeared in a very reputable on-line journal showing Affimers working in lots of fancy applications. Might not understand much of it but it shows how widely Affimers can be used which is obviously important. Paste this link into your browser if you want to read it. hxxp://lens.elifesci | e1nstein | |
27/6/2017 15:49 | Avacta present at our next Manchester growth company seminar on the 11th July, which may be of interest to potential investors and current shareholders. More details at: | sharesoc | |
19/6/2017 19:31 | Avacta presented at our London company seminar on the 14th June, their presentation slides are available on ShareSoc's member network, here: To access the slides, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here: Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the slides (and reports on 100s of other meetings). If you're already a member and have any difficulty accessing the presentation slides, please do not hesitate to contact us here: | sharesoc | |
08/6/2017 16:07 | With every passing week there is cashburn ... eventually, this has to stop. There is circumstantial evidence (details tied up in confidentiality clauses) that some commercial deals have reduced pressure, but until hard figures are released, there is every possibility that without news, there will be further drifting in the price | the drewster | |
08/6/2017 13:35 | Impatience. People expect developments every week. | mrangry2 | |
08/6/2017 12:08 | Jam tomorrow (still) which will always leave people to wonder IF commercial traction can beat the arrival of newer better options. | the drewster | |
08/6/2017 11:03 | Any ideas on why the share price is falling, given the good news flow? | lantanatony | |
26/5/2017 18:37 | impressive video, very exciting technology. Thanks again for posting. | tratante | |
22/5/2017 14:42 | Alistair is very decent, approachable and scientific. Strengthening the board with business brains was, in my view, very astute. We're certainly "getting there", and each deal, commercials undisclosed or not, MUST improve the cash position. | the drewster | |
22/5/2017 14:21 | That would be great, cheers. | tratante | |
22/5/2017 14:11 | I shall do It will follow but not now as I'm on my I phone and at work so need to wait till get home | escapetohome | |
22/5/2017 13:11 | Escape, would you be kind enough to post details of the whereabouts of the presentation, or a link? Just arrived on this bb. Thanks. | tratante | |
22/5/2017 12:28 | I think Alistair Smith is a good presenter. This man knows his stuff and he talks clearly, he cannot be fased. I think he is GSK material. | escapetohome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions